Xiao Dongdong, Wang Qiong, Yan Hao, Lv Xiangguo, Zhao Yang, Zhou Zhe, Zhang Ming, Sun Qian, Sun Kang, Li Wei, Lu Mujun
Department of Urology and Andrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China.
Department of Urology, The Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.
Oncotarget. 2017 Sep 23;8(49):86471-86487. doi: 10.18632/oncotarget.21211. eCollection 2017 Oct 17.
The unfavourable clinical outcomes of host cell-seeded scaffolds for bladder augmentation warrant improved bioactive biomaterials. This study aimed to examine the feasibility of adipose-derived stem cells (ASCs)-seeded bilayer bladder acellular matrix graft (BAMG)-silk fibroin (SF) scaffold in enhancing bladder reconstruction. Sprague Dawley rats were randomly divided into three groups: the BAMG-SF-ASCs group, the acellular BAMG-SF group and the cystotomy group. The BAMG-SF-ASCs group was sampled at 2, 4 and 12 weeks, and compared with the other groups at 12 weeks. In the BAMG-SF-ASCs group, the normal bladder contour was reformed similar to that in the cystotomy group, with abundant urothelium and smooth muscle regeneration, as well as a suitable scaffold degradation speed, and trivial fibrosis and inflammation. The ASCs seeded in BAMG-SF were maintained in the regenerated region during the 12-week experimental period and significantly enhanced the vessel density, nerve regeneration and bladder function compared with acellular BAMG-SF. In addition, the BAMG-SF-ASCs group presented elevated levels of SDF-1α, VEGF and their receptors, with an obvious increase in ERK 1/2 phosphorylation. BAMG-SF is a promising biomaterial for ASCs seeding to facilitate bladder augmentation and demonstrated an enhanced angiogenic potential possibly related to the SDF-1α/CXCR4 pathway via ERK 1/2 activation.
用于膀胱扩大术的宿主细胞接种支架的不良临床结果促使人们改进生物活性生物材料。本研究旨在探讨脂肪干细胞(ASC)接种的双层膀胱脱细胞基质移植物(BAMG)-丝素蛋白(SF)支架在增强膀胱重建方面的可行性。将Sprague Dawley大鼠随机分为三组:BAMG-SF-ASC组、脱细胞BAMG-SF组和膀胱切开术组。BAMG-SF-ASC组在第2、4和12周取样,并在第12周与其他组进行比较。在BAMG-SF-ASC组中,正常膀胱轮廓得以重塑,类似于膀胱切开术组,有丰富的尿路上皮和平滑肌再生,支架降解速度适宜,纤维化和炎症轻微。接种在BAMG-SF中的ASC在12周的实验期内维持在再生区域,与脱细胞BAMG-SF相比,显著提高了血管密度、神经再生和膀胱功能。此外,BAMG-SF-ASC组中SDF-1α、VEGF及其受体水平升高,ERK 1/2磷酸化明显增加。BAMG-SF是一种有前景的用于ASC接种以促进膀胱扩大术的生物材料,并且显示出增强的血管生成潜力,这可能与通过ERK 1/2激活的SDF-1α/CXCR4途径有关。